- Home
- GLBS vs ELUT Comparison
GLBS vs ELUT Comparison
Compare GLBS & ELUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GLBS | ELUT |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | Greece | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.8M | 42.5M |
| IPO Year | 2010 | 2020 |
Fundamental Metrics
Financial Performance| Metric | GLBS | ELUT |
|---|---|---|
| Price | $3.60 | $0.80 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 152.4K | 50.4K |
| Earning Date | 06-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 146.77 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,293,000.00 |
| Revenue This Year | $13.06 | N/A |
| Revenue Next Year | $20.20 | $10.83 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.01 | $0.50 |
| 52 Week High | $3.94 | $1.39 |
Technical Indicators
Market Signals| Indicator | GLBS | ELUT |
|---|---|---|
| Relative Strength Index (RSI) | 52.74 | 36.08 |
| Support Level | $3.37 | $0.51 |
| Resistance Level | $3.92 | $1.03 |
| Average True Range (ATR) | 0.22 | 0.08 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 56.25 | 1.39 |
Price Performance
Historical ComparisonAbout GLBS Globus Maritime Limited
Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.
About ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.